BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8813487)

  • 1. The place of octreotide in the medical management of the dumping syndrome.
    Scarpignato C
    Digestion; 1996; 57 Suppl 1():114-8. PubMed ID: 8813487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide improves early dumping syndrome potentially through incretins: a case report.
    Sato D; Morino K; Ohashi N; Ueda E; Ikeda K; Yamamoto H; Ugi S; Yamamoto H; Araki S; Maegawa H
    Endocr J; 2013; 60(7):847-53. PubMed ID: 23708181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. An update.
    Lamers CB; Bijlstra AM; Harris AG
    Dig Dis Sci; 1993 Feb; 38(2):359-64. PubMed ID: 8425449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide in dumping and short bowel syndromes.
    Farthing MJ
    Digestion; 1993; 54 Suppl 1():47-52. PubMed ID: 8359568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping.
    Arts J; Caenepeel P; Bisschops R; Dewulf D; Holvoet L; Piessevaux H; Bourgeois S; Sifrim D; Janssens J; Tack J
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):432-7. PubMed ID: 19264574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of octreotide-therapy in severe dumping syndrome.
    Vecht J; Lamers CB; Masclee AA
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):619-24. PubMed ID: 10594523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term symptomatic relief of postprandial hypoglycaemia following gastric surgery with a somatostatin analogue.
    D'Cruz DP; Reynard J; Tatman AJ; Kopelman PG
    Postgrad Med J; 1989 Feb; 65(760):116-7. PubMed ID: 2780462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome.
    Geer RJ; Richards WO; O'Dorisio TM; Woltering EO; Williams S; Rice D; Abumrad NN
    Ann Surg; 1990 Dec; 212(6):678-87. PubMed ID: 2256759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic value of octreotide for patients with severe dumping syndrome--a review of randomised controlled trials.
    Li-Ling J; Irving M
    Postgrad Med J; 2001 Jul; 77(909):441-2. PubMed ID: 11423592
    [No Abstract]   [Full Text] [Related]  

  • 10. Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome.
    Richards WO; Geer R; O'Dorisio TM; Robarts T; Parish KL; Rice D; Woltering G; Abumrad NN
    J Surg Res; 1990 Dec; 49(6):483-7. PubMed ID: 2263084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Could delayed action flanreotide be used as substitute for octreotide in the treatment of dumping syndrome?].
    Bouché O; Salmon-Ettersperger L; Frémond L; Thiéfin G; Zeitoun P
    Gastroenterol Clin Biol; 1997; 21(1):84-5. PubMed ID: 9091398
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome.
    Hasler WL; Soudah HC; Owyang C
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1359-65. PubMed ID: 8667198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long acting somatostatin analogue in dumping syndrome.
    Tulassay Z; Tulassay T; Gupta R; Cierny G
    Br J Surg; 1989 Dec; 76(12):1294-5. PubMed ID: 2691013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome.
    Penning C; Vecht J; Masclee AA
    Aliment Pharmacol Ther; 2005 Nov; 22(10):963-9. PubMed ID: 16268971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide in the treatment of the dumping syndrome.
    Primrose JN
    Digestion; 1990; 45 Suppl 1():49-58; discussion 58-9. PubMed ID: 2335268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of peptide hormone ligands for the treatment of dumping and short bowel syndrome.
    Wauters L; Vanuytsel T
    Curr Opin Pharmacol; 2018 Dec; 43():118-123. PubMed ID: 30273889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dumping syndrome. Current insights into pathophysiology, diagnosis and treatment.
    Vecht J; Masclee AA; Lamers CB
    Scand J Gastroenterol Suppl; 1997; 223():21-7. PubMed ID: 9200302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy.
    Primrose JN; Johnston D
    Br J Surg; 1989 Feb; 76(2):140-4. PubMed ID: 2702445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of severe postgastrectomy dumping with a long-acting somatostatin analog: is effective management finally available?
    Miller TA
    Gastroenterology; 1991 Oct; 101(4):1129-30. PubMed ID: 1889706
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of somatostatin in dumping syndrome after gastric surgery.
    Tulassay Z; Tulassay T; Gupta R; Tamás G
    Acta Gastroenterol Belg; 1993; 56(2):219-22. PubMed ID: 8103615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.